TR study of ‘multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer"
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2645675
下载链接
链接失效反馈官方服务：
资源简介：
Primary outcome(s): Cancer-related gene alteration, expression of protein, and expression of RNA
创建时间：
2017-12-15
